期刊文献+

盐酸纳络酮对颅脑损伤患者血清C-反应蛋白影响的临床研究 被引量:1

Effect of naloxone on the concentration of plasma C-reaction protein following brain injuries
下载PDF
导出
摘要 目的通过动态观察盐酸纳络酮对颅脑损伤患者血清C-反应蛋白浓度的影响,进一步探讨盐酸纳络酮在颅脑损伤治疗中的作用。方法将80例颅脑损伤患者随机分为纳络酮组和常规组。纳络酮组在常规治疗的基础上加用盐酸纳络酮,即入院后立即缓慢静脉推注4mg后以0.4mg/kg/天静脉泵持续静脉滴注,3天后改为0.2mg/kg/天,至第10天停药。两组患者于入院后24小时内和第10天检测血清C-反应蛋白浓度。治疗后3月采用GOS评分比较预后。结果两组患者血清C-反应蛋白浓度明显高于正常对照组(P<0.05);纳络酮组血清C-反应蛋白浓度明显低于常规组(P<0.05);纳络酮组治疗后3个月GOS评分明显高于常规组(P<0.05)。结论颅脑损伤患者血清C-反应蛋白浓度明显升高,盐酸纳络酮能显著降低患者血清C-反应蛋白浓度,保护神经功能,改善预后。 Objective Through observation the effect of naloxone on concentration of plasma C-reaction protein following brain injuries, to explore the treatment effect of edaravone on brain injury patients. Methods A total of 80 patients with brain injuries were divided into naloxone group and general group randomly. The patients of naloxone group were treated with naloxone besides general treatment. Concentration of C-reaction protein in serum was measured in all patients in 24h and 10d after hospitalization. Prognosis were evaluated after 3 month. Results The concentration of C-reaction protein in serum of both groups were significantly higher than of norulal group (P〈0.05) ; The concentration of C-reaction protein in serum of naloxone group were significantly lower than of general group(P〈0.05). The GOS grade of naloxone group were significantly higher than of general group after 3 month (P〈0.05). Conclusion The concentration of C-reaction protein in serum elevated significantly after brain injuries, naloxone could lower the concentration of C-reaction protein in serum ,protect neurofunetion and improve prognosis. ;
出处 《浙江创伤外科》 2009年第3期207-209,共3页 Zhejiang Journal of Traumatic Surgery
关键词 纳络酮 颅脑损伤 C-反应蛋白 预后 Naloxone Brain injury C-reaction protein Prognosis
  • 相关文献

参考文献8

  • 1吴添沐,吴松鹰.C反应蛋白与脑梗死相关性的研究进展[J].医学综述,2007,13(7):525-527. 被引量:13
  • 2梁志忠,黄志雄,林启明,陈旭,王向宇.早期大剂量纳络酮治疗重型颅脑损伤的临床观察[J].中华神经医学杂志,2006,5(2):197-198. 被引量:29
  • 3Roberts WL,Sedrick R,Moulton L,et al.Evaluation of four antomated high-sensitivity C reactive protein methods:implications for clinical and epidemiological applications[J].Clin Chem,2003,46(4):461-468.
  • 4Frati A,Salvati M,Mainiero F,et al.Inflammation markers and risk factors for recurrence in 35 patients with a post traumatic chronic subdural hematoma:a prospective study[J].J Neurosurg,2004,100(1):24-32.
  • 5Oconnor E,Venkatesh B,Mashongonyika C,et al.Serum procalcitonin and C-reactive protein as markers of sepsis and outcome in patients with neurotrauma and subarachnoid haemorrhage[J].Anacsth Intensive Care,2004,32(4):465-470.
  • 6Wilcockson DC,Campbell SJ,Anthony DC,et al.The systemic and local acute phase response following acute brain injury[J].J Cereb Blood Flow Metab,2002,22(3):318-326.
  • 7Oconnor E,Venkatesh B,Mashongonyika C,et al.Serum procalcitonin and C-reactive protein as markers of sepsis and outcome in patients with neuro trauma and subarachnoid haemorrhage[J].Anaesth Intensive Care,2004,32(4):465-470.
  • 8郝学红,冶玉虎.早期大剂量纳络酮治疗重型颅脑损伤80例临床观察[J].山东医药,2008,48(27):129-130. 被引量:3

二级参考文献28

共引文献40

同被引文献5

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部